DYNAMO Trademark

Trademark Overview

On Thursday, May 14, 2020, a trademark application was filed for DYNAMO with the United States Patent and Trademark Office. The USPTO has given the DYNAMO trademark a serial number of 88915496. The federal status of this trademark filing is REGISTERED as of Tuesday, August 6, 2024. This trademark is owned by Relay Therapeutics, Inc.. The DYNAMO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug discovery services; pharmaceutical and biotechnology research and development services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery
dynamo

General Information

Serial Number88915496
Word MarkDYNAMO
Filing DateThursday, May 14, 2020
Status700 - REGISTERED
Status DateTuesday, August 6, 2024
Registration Number7469114
Registration DateTuesday, August 6, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements

Goods and ServicesPharmaceutical drug discovery services; pharmaceutical and biotechnology research and development services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 28, 2020
Primary Code042
First Use Anywhere DateTuesday, June 30, 2020
First Use In Commerce DateTuesday, June 30, 2020

Trademark Owner History

Party NameRelay Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRelay Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRelay Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, May 18, 2020NEW APPLICATION ENTERED
Thursday, May 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 16, 2021FINAL REFUSAL WRITTEN
Wednesday, August 12, 2020ASSIGNED TO EXAMINER
Tuesday, August 18, 2020NON-FINAL ACTION WRITTEN
Tuesday, August 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 18, 2020NON-FINAL ACTION E-MAILED
Thursday, February 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 18, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 16, 2021FINAL REFUSAL E-MAILED
Tuesday, March 16, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 16, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, September 16, 2021EXPARTE APPEAL RECEIVED AT TTAB
Thursday, September 16, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, September 16, 2021EX PARTE APPEAL-INSTITUTED
Wednesday, September 22, 2021ASSIGNED TO LIE
Wednesday, September 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 18, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 18, 2021SUSPENSION LETTER WRITTEN
Monday, October 18, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, June 15, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, November 22, 2022SUSPENSION LETTER WRITTEN
Tuesday, November 22, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, November 22, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 5, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, May 23, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, July 7, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, May 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 9, 2023EXPARTE APPEAL TERMINATED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 3, 2023SOU EXTENSION 1 FILED
Friday, November 3, 2023USE AMENDMENT FILED
Friday, November 3, 2023TEAS STATEMENT OF USE RECEIVED
Friday, May 17, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 3, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 6, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, November 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 8, 2023SOU EXTENSION 1 GRANTED
Thursday, November 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

dynamo pharmaceutical development services research drug discovery field medicines design biotechnology